These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33619893)

  • 21. Long-term monitoring of respiratory rate in patients with heart failure: the Multiparametric Heart Failure Evaluation in Implantable Cardioverter-Defibrillator Patients (MULTITUDE-HF) study.
    Forleo GB; Santini L; Campoli M; Malavasi M; Scaccia A; Menichelli M; Riva U; Lamberti F; Carreras G; Orazi S; Ribatti V; Di Biase L; Lovecchio M; Natale A; Valsecchi S; Romeo F
    J Interv Card Electrophysiol; 2015 Aug; 43(2):135-44. PubMed ID: 25917747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting.
    Cowie MR; Sarkar S; Koehler J; Whellan DJ; Crossley GH; Tang WH; Abraham WT; Sharma V; Santini M
    Eur Heart J; 2013 Aug; 34(31):2472-80. PubMed ID: 23513212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT; Compton S; Haas G; Foreman B; Canby RC; Fishel R; McRae S; Toledo GB; Sarkar S; Hettrick DA;
    Congest Heart Fail; 2011; 17(2):51-5. PubMed ID: 21449992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE-HF study.
    Virani SA; Sharma V; McCann M; Koehler J; Tsang B; Zieroth S
    ESC Heart Fail; 2018 Oct; 5(5):809-817. PubMed ID: 29934976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
    Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
    Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.
    Sharma V; Rathman LD; Small RS; Whellan DJ; Koehler J; Warman E; Abraham WT
    Heart Lung; 2015; 44(2):129-36. PubMed ID: 25543319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure.
    Martens P; Dupont M; Verbrugge FH; Damman K; Degryse N; Nijst P; Reynders C; Penders J; Tang WHW; Testani J; Mullens W
    JACC Heart Fail; 2019 May; 7(5):404-414. PubMed ID: 31047021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
    Gheorghiade M; Greene SJ; Butler J; Filippatos G; Lam CS; Maggioni AP; Ponikowski P; Shah SJ; Solomon SD; Kraigher-Krainer E; Samano ET; Müller K; Roessig L; Pieske B;
    JAMA; 2015 Dec; 314(21):2251-62. PubMed ID: 26547357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
    Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
    J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.